Evidence-Based Oncology
Conference Coverage
Volume: 18
Issue: SP6
December
Volume: 18
Issue: SP5
September
Volume: 18
Issue: SP4
May
Volume: 18
Issue: SP3
February
Volume: 18
Issue: SP1
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates
4
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
5
